Event Overview

Suraksha Diagnostic Limited has intimated the stock exchanges about scheduling an Analysts/Institutional Investors/Organizations meet pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company will host a Conference Call designated as 'Earnings Call' to discuss the Q2 Financial Results for the quarter and half year ended 30th September, 2026.

Key Event Details

Date: Friday, 13th November, 2026

Time: 11:00 A.M. (IST)

Event Type: Discussion on Q2 Financial Results

Mode: Virtual/Digital means

Meeting Type: Group meet

Company Participants

  • Dr. Somnath Chatterjee (Chairman & Joint Managing Director)
  • Ms. Ritu Mittal (Joint Managing Director & Chief Executive Officer)
  • Mr. Dinesh Gupta (Chief Financial Officer)
  • Mr. Niren Kaul (Chief Sales Officer)
  • Mr. Balgopal Jhunjhunwala (Regional Business Head)

Conference Dial-in Information

Universal Dial In: +91 22 6280 1550 / +91 22 7115 8378

International Toll Free:

  • Hong Kong: 800964448
  • UK: 08081011573
  • Singapore: 8001012045
  • USA: 18667462133

Pre-registration: Participants are advised to pre-register using the Diamond Pass link to avoid wait time: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=1638954&linkSecurityString=eb2e49d86